4.8 Article

Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

期刊

NATURE COMMUNICATIONS
卷 11, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-020-15701-2

关键词

-

资金

  1. government of Canada through the tri-council Vanier Canada Graduate Doctoral Fellowship
  2. Ludmer Centre for Neuroinformatics and Mental Health
  3. Healthy Brains for Healthy Lives initiative
  4. European Research Council
  5. Swedish Research Council
  6. Knut and Alice Wallenberg foundation
  7. Marianne and Marcus Wallenberg foundation
  8. Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University
  9. Swedish Alzheimer Foundation
  10. Swedish Brain Foundation
  11. Parkinson foundation of Sweden
  12. Parkinson Research Foundation
  13. Skane University Hospital Foundation
  14. Swedish federal government under the ALF agreement
  15. GE Healthcare
  16. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]
  17. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  18. National Institute on Aging
  19. National Institute of Biomedical Imaging and Bioengineering
  20. AbbVie
  21. Alzheimer's Association
  22. Alzheimer's Drug Discovery Foundation
  23. Araclon Biotech
  24. BioClinica, Inc.
  25. Biogen
  26. Bristol-Myers Squibb Company
  27. CereSpir, Inc.
  28. Cogstate
  29. Eisai Inc.
  30. Elan Pharmaceuticals, Inc.
  31. Eli Lilly and Company
  32. EuroImmun
  33. F. Hoffmann-La Roche Ltd
  34. company Genentech, Inc.
  35. Fujirebio
  36. IXICO Ltd
  37. Janssen Alzheimer Immunotherapy Research & Development, LLC
  38. Johnson & Johnson Pharmaceutical Research & Development LLC
  39. Lumosity
  40. Lundbeck
  41. Merck Co., Inc.
  42. Meso Scale Diagnostics, LLC
  43. NeuroRx Research
  44. Neurotrack Technologies
  45. Novartis Pharmaceuticals Corporation
  46. Pfizer Inc.
  47. Piramal Imaging
  48. Servier
  49. Takeda Pharmaceutical Company
  50. Transition Therapeutics
  51. Canadian Institutes of Health Research

向作者/读者索取更多资源

Tau is a hallmark pathology of Alzheimer's disease, and animal models have suggested that tau spreads from cell to cell through neuronal connections, facilitated by beta -amyloid (A beta). We test this hypothesis in humans using an epidemic spreading model (ESM) to simulate tau spread, and compare these simulations to observed patterns measured using tau-PET in 312 individuals along Alzheimer's disease continuum. Up to 70% of the variance in the overall spatial pattern of tau can be explained by our model. Surprisingly, the ESM predicts the spatial patterns of tau irrespective of whether brain A beta is present, but regions with greater A beta burden show greater tau than predicted by connectivity patterns, suggesting a role of A beta in accelerating tau spread. Altogether, our results provide evidence in humans that tau spreads through neuronal communication pathways even in normal aging, and that this process is accelerated by the presence of brain A beta. The tau protein is theorized to spread transneuronally in Alzheimers disease, though this theory remains unproven in humans. Our simulations of epidemic-like protein spreading across human brain networks support this theory, and suggest the spreading dynamics are modified by beta -amyloid

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据